Erste Asset Management’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Hold |
14,000
| – | – | ﹤0.01% | 828 |
|
|
2025
Q1 | $126K | Hold |
14,000
| – | – | ﹤0.01% | 486 |
|
|
2024
Q4 | $204K | Hold |
14,000
| – | – | ﹤0.01% | 486 |
|
|
2024
Q3 | $325K | Hold |
14,000
| – | – | ﹤0.01% | 466 |
|
|
2024
Q2 | $284K | Hold |
14,000
| – | – | ﹤0.01% | 453 |
|
|
2024
Q1 | $344K | Hold |
14,000
| – | – | ﹤0.01% | 452 |
|
|
2023
Q4 | $262K | Hold |
14,000
| – | – | ﹤0.01% | 471 |
|
|
2023
Q3 | $283K | Hold |
14,000
| – | – | ﹤0.01% | 458 |
|
|
2023
Q2 | $349K | Hold |
14,000
| – | – | 0.01% | 454 |
|
|
2023
Q1 | $305K | Hold |
14,000
| – | – | 0.01% | 471 |
|
|
2022
Q4 | $414K | Hold |
14,000
| – | – | 0.01% | 440 |
|
|
2022
Q3 | $333K | Hold |
14,000
| – | – | 0.01% | 465 |
|
|
2022
Q2 | $240K | Hold |
14,000
| – | – | 0.01% | 500 |
|
|
2022
Q1 | $596K | Hold |
14,000
| – | – | 0.01% | 421 |
|
|
2021
Q4 | $822K | Buy |
+14,000
| New | +$822K | 0.01% | 378 |
|